Amesite Inc. - AMST

About Gravity Analytica
Recent News
- 04.22.2025 - Amesite Announces NurseMagic™ Meets HIPAA Requirements for Individuals Users, in Addition to Enterprises
- 04.22.2025 - Amesite Announces NurseMagic™ Meets HIPAA Requirements for Individuals Users, in Addition to Enterprises
- 04.04.2025 - Amesite (Nasdaq: AMST) Anticipates Sales Growth Amid Shifting Trade Dynamics
- 04.04.2025 - Amesite (Nasdaq: AMST) Anticipates Sales Growth Amid Shifting Trade Dynamics
- 03.11.2025 - Amesite Announces Successful Soft Rollout of NurseMagic™ Caregiver Solution, Expanding Its Addressable Market for Enterprise by 50%
- 03.11.2025 - Amesite Announces Successful Soft Rollout of NurseMagic™ Caregiver Solution, Expanding Its Addressable Market for Enterprise by 50%
- 03.05.2025 - Amesite Announces NurseMagic™ Sales Growth for Hospice Care Team with Documentation Solution to Ensure Reimbursements, Reduce Audit Risk for Owners
- 03.05.2025 - Amesite Announces NurseMagic™ Sales Growth for Hospice Care Team with Documentation Solution to Ensure Reimbursements, Reduce Audit Risk for Owners
- 02.25.2025 - Amesite Announces Enterprise Sales Growth with Automated Sales Flow for NurseMagic™ Business Customers
- 02.25.2025 - Amesite Announces Enterprise Sales Growth with Automated Sales Flow for NurseMagic™ Business Customers
Recent Filings
- 04.02.2025 - 4 Statement of changes in beneficial ownership of securities
- 04.02.2025 - 4 Statement of changes in beneficial ownership of securities
- 04.02.2025 - 4 Statement of changes in beneficial ownership of securities
- 04.02.2025 - 4 Statement of changes in beneficial ownership of securities
- 03.11.2025 - 4 Statement of changes in beneficial ownership of securities
- 03.11.2025 - 4 Statement of changes in beneficial ownership of securities
- 03.11.2025 - 4 Statement of changes in beneficial ownership of securities
- 03.11.2025 - 4 Statement of changes in beneficial ownership of securities
- 02.19.2025 - 8-K Current report
- 02.07.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]